logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5758.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.5758.produseast1
Showing 1 - 13 of 13 Items
Showing 1 - 13 of 13 Items
Citations
  • Download citations in various formats (CSV, BibTeX, EndNote) for use in reference managers and bibliographies.
  • Current Page (13)
  • CSV
  • BibTeX
  • EndNote
  • All Results (13)
  • CSV
  • BibTeX
  • EndNote
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Review

Cutaneous leishmaniasis in Afghanistan

Rahimi BA, Ghatee MA, Habib MN, Farooqi K, Ritmeijer K,  et al.
2025-05-07 • Transactions of the Royal Society of Tropical Medicine and Hygiene
2025-05-07 • Transactions of the Royal Society of Tropical Medicine and Hygiene

Old World cutaneous leishmaniasis (OWCL) is a sand fly-transmitted skin infection caused by Leishmania species that extends from West Africa to China. Afghanistan probably has the hig...

Journal Article
|
Commentary
Journal Article
|
Research
Conference Material
|
Poster

Improving the patient journey and reducing stigma for people with cutaneous leishmaniasis in Brazil, Ethiopia, and Sri Lanka: findings from the ECLIPSE programme

Price H, Agampodi S, Dikomitis L, Machado P, Mulugeta A,  et al.
Journal Article
|
Editorial
Journal Article
|
Research
Conference Material
|
Video

Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy combination in uncomplicated New World cutaneous leishmaniasis

Arana B
2020-05-13 • MSF Scientific Days International 2020
2020-05-13 • MSF Scientific Days International 2020
Conference Material
|
Poster
Conference Material
|
Abstract
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Case Report/Series

Disease-specific differences in pharmacokinetics of paromomycin and miltefosine between post-kala-azar dermal leishmaniasis and visceral leishmaniasis patients in eastern Africa

Chu WY, Verrest L, Younis BM, Musa AM, Mbui J,  et al.
2024-12-16 • Journal of Infectious Diseases
2024-12-16 • Journal of Infectious Diseases

Treatment regimens for post-kala-azar dermal leishmaniasis (PKDL) are usually extrapolated from those for visceral leishmaniasis (VL), but drug pharmacokinetics (PK) can differ due to...

A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh

Sundar S, Pandey K, Mondal D, Madhukar M, Kamal Topno R,  et al.
2024-06-20 • PLOS Neglected Tropical Diseases
2024-06-20 • PLOS Neglected Tropical Diseases
BACKGROUND
In Southeast Asia, treatment is recommended for all patients with post-kala-azar dermal leishmaniasis (PKDL). Adherence to the first-line regimen, twelve weeks of miltefos...
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024

Therapeutic strategies against leishmania and trypanosoma

Santos ALS, Rodrigues IA, d’Avila-Levy CM, Sodré CL, Ritmeijer KKD,  et al.
2023-10-19 • Pathogens
2023-10-19 • Pathogens
Human African trypanosomiasis (also known as sleeping sickness, with Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense as etiological agents), American trypanosomiasis (als...

A comparison of the effectiveness of sodium stibogluconate monotherapy to sodium stibogluconate and paromomycin combination for the treatment of severe post kala azar dermal leishmaniasis in South Sudan - A retrospective cohort study

Abongomera C, Gatluak F, Buyze J, Ritmeijer KKD
2016-09-22 • PLOS One
2016-09-22 • PLOS One
BACKGROUND
Post-kala-azar dermal leishmaniasis (PKDL) is a common dermatological complication following successful treatment of Visceral Leishmaniasis (VL) caused by Leishmania donov...

Patient characteristics and treatment outcomes from MSF's cutaneous leishmaniasis programme in Pakistan: a retrospective cohort

Kamink SS, Masih B, Saleem A, Khan J, Masih S,  et al.
2021-05-18 • MSF Scientific Days International 2021: Research
2021-05-18 • MSF Scientific Days International 2021: Research

Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy combination in uncomplicated New World cutaneous leishmaniasis

Arana B, Lopez L, Velez ID, Llanos-Cuentas A, Boni MF,  et al.
2020-05-13 • MSF Scientific Days International 2020
2020-05-13 • MSF Scientific Days International 2020

Prevalence and determinants of asymptomatic Leishmania infection in HIV-infected individuals living within visceral leishmaniasis endemic areas of Bihar, India

Mahajan R, Owen SI, Pandey K, Kazmi S, Kumar V,  et al.
2022-08-30 • PLOS Neglected Tropical Diseases
2022-08-30 • PLOS Neglected Tropical Diseases
People living with HIV (PLHIV) have an increased risk of developing visceral leishmaniasis (VL) and poor outcomes compared to HIV negative individuals. Here, we aim to establish the prev...

Epidemiological changes in Leishmaniasis in Spain according to hospitalization-based records, 1997-2011: raising awareness towards Leishmaniasis in non-HIV patients

Herrador Z, Gherasim A, Jimenez BC, Granados M, San Martin JV,  et al.
2015-03-10 • PLOS Neglected Tropical Diseases
2015-03-10 • PLOS Neglected Tropical Diseases
In Spain, Leishmania infantum is endemic, human visceral and cutaneous leishmaniasis cases occurring both in the Peninsula, as well as in the Balearic Islands. We aimed to describe the c...

Control of mucocutaneous leishmaniasis, a neglected disease: results of a control programme in Satipo Province, Peru

Guthmann JP, Arlt D, Garcia LML, Rosales M, Jesus Sanchez J,  et al.
2005-09-01 • Tropical Medicine and International Health
2005-09-01 • Tropical Medicine and International Health
Mucocutaneous leishmaniasis (MCL) is an important health problem in many rural areas of Latin America, but there are few data on the results of programmatic approaches to control the dis...

Hypokalaemia-induced rhabdomyolysis after treatment of post-kala-azar dermal leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh - A case report

Marking U, den Boer ML, Das AK, Ahmed EM, Rollason V,  et al.
2014-06-12 • PLOS Neglected Tropical Diseases
2014-06-12 • PLOS Neglected Tropical Diseases